,mean_rank,weight
cervix,10.0,3.0
adrenal gland neuroblastoma,15.0,5.0
adrenal gland,31.0,3.0
neuroblastoma,37.0,52.0
endometrioid stromal sarcoma,44.0,3.0
small cell lung carcinoma,45.5,88.0
right pararenal lymph node,47.0,2.0
lung carcinoma,48.0,1.0
medulloblastoma,48.5,8.0
pancreatic somatostatinoma,49.0,3.0
cervical small cell carcinoma,52.0,1.0
vertebra,58.5,2.0
supraclavicular lymph node,63.0,3.0
supra-orbital region,64.0,1.0
testicular embryonal carcinoma,66.0,1.0
hereditary thyroid gland medullary carcinoma,70.0,1.0
multiple endocrine neoplasia type 2,70.0,1.0
prostate carcinoma,71.0,11.0
"squamous cell breast carcinoma, acantholytic variant",76.0,3.0
thyroid gland squamous cell carcinoma,81.0,3.0
embryonal carcinoma,82.0,1.0
gastric small cell neuroendocrine carcinoma,93.0,4.0
lung carcinoid tumor,101.5,6.0
pharyngeal squamous cell carcinoma,106.0,3.0
large cell lung carcinoma,107.5,32.0
mediastinal lymph node,112.0,1.0
brain,116.5,16.0
right thigh skin,118.0,2.0
ewing sarcoma,118.0,31.0
rhabdomyosarcoma,121.0,4.0
salivary gland squamous cell carcinoma,121.0,3.0
skin nodule,125.0,1.0
"childhood chronic myelogenous leukemia, bcr-abl1 positive",132.0,2.0
tonsillar squamous cell carcinoma,134.0,1.0
lung giant cell carcinoma,137.5,4.0
subserosa of fallopian tube,149.0,1.0
high grade ovarian serous adenocarcinoma,163.0,40.0
myeloid leukemia associated with down syndrome,172.0,1.0
bone marrow,178.0,65.0
not specified,179.0,3.0
cervical carcinoma,181.0,2.0
alveolar rhabdomyosarcoma,191.0,9.0
hypopharyngeal squamous cell carcinoma,193.0,5.0
endometrial carcinoma,194.5,8.0
minimally invasive lung adenocarcinoma,203.0,16.0
abdomen,203.5,2.0
brca1 syndrome,204.0,1.0
cervical squamous cell carcinoma,210.0,1.0
bronchogenic carcinoma,212.5,2.0
ovarian carcinoma,213.5,6.0
liposarcoma,219.0,1.0
ovarian serous cystadenocarcinoma,219.0,4.0
ovarian endometrioid adenocarcinoma,221.0,11.0
ovarian granulosa cell tumor,222.0,2.0
askin tumor,222.5,2.0
squamous cell lung carcinoma,230.5,48.0
brca2 syndrome,232.0,1.0
epithelioid cell type gastrointestinal stromal tumor,232.0,3.0
lung mucoepidermoid carcinoma,233.0,3.0
abdominal wall,238.5,2.0
biphasic synovial sarcoma,241.0,1.0
embryonal rhabdomyosarcoma,243.5,6.0
gastric adenosquamous carcinoma,244.0,2.0
uterine carcinosarcoma,244.0,2.0
primitive neuroectodermal tumor,248.5,2.0
burkitt lymphoma,251.0,8.0
osteosarcoma,255.0,23.0
esophageal squamous cell carcinoma,258.0,59.0
papillary renal cell carcinoma,258.0,5.0
pyriform fossa squamous cell carcinoma,259.0,1.0
skin squamous cell carcinoma,261.0,1.0
cervical lymph node,270.0,5.0
adenosquamous lung carcinoma,281.0,9.0
duodenal adenocarcinoma,288.0,1.0
adult b acute lymphoblastic leukemia,289.0,3.0
intraperitoneal,289.0,1.0
mucinous gastric adenocarcinoma,289.0,3.0
mandible,291.0,1.0
lung adenocarcinoma,300.0,145.0
recurrent bladder carcinoma,301.0,3.0
childhood acute myeloid leukemia with maturation,303.0,1.0
intrahepatic cholangiocarcinoma,305.5,6.0
pleural effusion,307.5,224.0
uterine corpus sarcoma,309.0,3.0
ovarian serous adenocarcinoma,312.0,7.0
ascites,312.0,103.0
bladder squamous cell carcinoma,314.0,3.0
gastric fundus carcinoma,319.0,1.0
endometrial adenosquamous carcinoma,319.5,6.0
poorly differentiated thyroid gland carcinoma,323.0,3.0
gastric carcinoma,323.5,12.0
erythroleukemia,324.0,3.0
hodgkin lymphoma,325.0,11.0
tongue squamous cell carcinoma,329.0,34.0
lymph node,332.0,105.0
plasma cell myeloma,334.5,30.0
ovarian adenocarcinoma,335.0,5.0
adult t acute lymphoblastic leukemia,341.0,5.0
malignant ovarian brenner tumor,342.0,1.0
right anterior leg,345.0,3.0
laryngeal squamous cell carcinoma,346.0,12.0
omentum,347.0,7.0
gastric choriocarcinoma,347.0,1.0
lung,348.0,7.0
diffuse large b-cell lymphoma germinal center b-cell type,348.5,8.0
undifferentiated gallbladder carcinoma,349.0,1.0
spleen,354.0,3.0
peritoneal effusion,354.0,6.0
ovarian leiomyosarcoma,355.0,3.0
rhabdoid tumor of the kidney,357.0,3.0
peritoneal ascites,357.0,2.0
pleural biphasic mesothelioma,359.0,7.0
ductal breast carcinoma,359.0,32.0
oral cavity squamous cell carcinoma,362.0,6.0
breast carcinoma,364.0,27.0
invasive lobular breast carcinoma,366.0,1.0
gastric tubular adenocarcinoma,369.0,11.0
cerebrospinal fluid,373.0,3.0
human papillomavirus-related endocervical adenocarcinoma,373.5,4.0
lymphoblastic lymphoma,378.0,1.0
breast adenocarcinoma,378.0,23.0
ovarian mucinous adenocarcinoma,378.0,4.0
oligodendroglioma,379.0,5.0
esophageal adenocarcinoma,380.0,9.0
neurofibromatosis type 1,380.0,1.0
squamous papilloma,381.0,1.0
gingival squamous cell carcinoma,381.0,2.0
hepatocellular carcinoma,383.0,51.0
mantle cell lymphoma,384.5,6.0
pancreatic adenocarcinoma,385.0,39.0
subcutaneous,385.0,7.0
small intestine,392.0,1.0
"invasive ductal carcinoma, not otherwise specified",392.0,30.0
skin,393.0,3.0
marek disease,393.0,1.0
bladder carcinoma,394.0,51.0
epstein-barr virus-related burkitt lymphoma,396.5,10.0
pleural sarcomatoid mesothelioma,397.0,8.0
liver,397.5,32.0
human papillomavirus-related cervical squamous cell carcinoma,398.5,8.0
peritoneum,399.0,1.0
anaplastic large cell lymphoma,400.0,8.0
natural killer cell lymphoblastic leukemia/lymphoma,401.0,1.0
adult acute monocytic leukemia,404.0,5.0
n/a,405.5,34.0
chronic lymphocytic leukemia,406.0,2.0
non-small cell lung carcinoma,410.0,24.0
cecum adenocarcinoma,411.0,18.0
childhood t acute lymphoblastic leukemia,413.0,19.0
diffuse large b-cell lymphoma,415.5,20.0
pancreatic carcinoma,416.5,12.0
thyroid gland undifferentiated (anaplastic) carcinoma,419.0,13.0
axillary lymph node,421.5,6.0
glioblastoma,422.0,84.0
cystic fibrosis,422.0,2.0
gastric adenocarcinoma,425.0,26.0
childhood t lymphoblastic lymphoma,425.5,2.0
pancreatic ductal adenocarcinoma,429.0,39.0
melanoma,430.5,94.0
peripheral blood,433.0,107.0
"chronic myelogenous leukemia, bcr-abl1 positive",434.0,16.0
cutaneous melanoma,434.5,26.0
bone,440.0,1.0
inguinal lymph node,441.0,3.0
b acute lymphoblastic leukemia,443.0,5.0
floor of mouth squamous cell carcinoma,444.0,1.0
celiac axis lymph node,448.5,2.0
pelvis; innominate bone,448.5,2.0
left leg muscle,449.0,3.0
ampulla of vater adenocarcinoma,449.5,2.0
clear cell renal cell carcinoma,450.0,18.0
childhood acute myeloid leukemia,451.0,2.0
anaplastic astrocytoma,452.0,5.0
amelanotic melanoma,453.0,16.0
acute myeloid leukemia,454.0,1.0
groin lymph node,458.0,5.0
gallbladder carcinoma,458.0,2.0
hairy cell leukemia,462.0,3.0
pleural epithelioid mesothelioma,462.0,18.0
mediastinal (thymic) large b-cell lymphoma,463.0,1.0
ovarian cystadenocarcinoma,463.5,6.0
myelodysplastic syndrome,468.0,1.0
endometrial adenocarcinoma,469.5,34.0
astrocytoma,470.0,19.0
benign prostatic hyperplasia,470.0,1.0
chondrosarcoma,473.5,10.0
down syndrome,473.5,2.0
pericardial effusion,475.0,8.0
renal cell carcinoma,477.0,37.0
hepatoblastoma,478.5,4.0
ovarian clear cell adenocarcinoma,484.0,13.0
signet ring cell gastric adenocarcinoma,491.0,9.0
uterine corpus leiomyosarcoma,497.0,3.0
colon adenocarcinoma,499.0,61.0
lymphoma,500.0,1.0
thyroid gland follicular carcinoma,502.5,10.0
b acute lymphoblastic leukemia with t(1;19)(q23;p13.3) e2a-pbx1 (tcf3-pbx1),503.5,4.0
barrett adenocarcinoma,504.0,3.0
fibrosarcoma,509.0,5.0
familial adenomatous polyposis,511.0,1.0
vulvar carcinoma,512.0,1.0
undifferentiated pleomorphic sarcoma,512.5,4.0
pelvic wall,513.0,3.0
ovarian mucinous cystadenocarcinoma,516.5,2.0
adult acute myeloid leukemia,520.0,22.0
pancreatic adenosquamous carcinoma,521.0,5.0
"endometrial endometrioid adenocarcinoma, variant with squamous differentiation",540.0,2.0
brachialis muscle,550.0,3.0
b-cell non-hodgkin lymphoma,551.0,7.0
mycosis fungoides and sezary syndrome,553.0,2.0
acute myelomonocytic leukemia,562.0,1.0
meninges,562.0,1.0
left supraclavicular lymph node,568.0,4.0
b acute lymphoblastic leukemia with t(v;11q23) kmt2a rearranged,570.0,3.0
childhood b acute lymphoblastic leukemia,570.0,9.0
ovarian mixed germ cell tumor,571.0,1.0
rectal adenocarcinoma,573.0,11.0
vulvar leiomyosarcoma,576.0,3.0
colon carcinoma,576.0,19.0
parotid gland mucoepidermoid carcinoma,577.0,1.0
gestational choriocarcinoma,581.0,2.0
papillary lung adenocarcinoma,589.0,3.0
paragastric lymph node,592.5,2.0
primary effusion lymphoma,593.0,3.0
rectosigmoid adenocarcinoma,593.0,3.0
b-cell prolymphocytic leukemia,596.0,2.0
cutaneous t-cell non-hodgkin lymphoma,596.0,2.0
hilar cholangiocarcinoma,596.0,1.0
childhood acute monocytic leukemia,606.5,2.0
follicular lymphoma,611.0,2.0
buccal mucosa squamous cell carcinoma,613.5,2.0
gliosarcoma,629.0,6.0
obturator lymph node,631.0,3.0
subcutaneous; right buttock,633.0,3.0
diffuse large b-cell lymphoma activated b-cell type,633.0,1.0
thyroid gland sarcoma,659.0,1.0
buttock,692.5,2.0
"chronic eosinophilic leukemia, not otherwise specified",697.0,1.0
head and neck squamous cell carcinoma,707.0,9.0
cholangiocarcinoma,710.5,2.0
hereditary spherocytosis,714.0,1.0
vulvar squamous cell carcinoma,724.0,3.0
right axillary lymph node,728.0,1.0
adrenal cortex carcinoma,771.0,1.0
squamous cell carcinoma,780.0,1.0
acute promyelocytic leukemia with t(15;17)(q22;q12) pml-rara,784.0,1.0
thigh skin,792.0,1.0
pleural malignant mesothelioma,799.0,5.0
thoracic lymph duct,831.0,1.0
vaginal melanoma,851.0,1.0
epithelioid sarcoma,902.0,1.0
oral dysplasia,903.0,1.0
ovary,910.0,1.0
splenic lymphoma with circulating villous lymphocytes,936.0,1.0
thyroid gland papillary carcinoma,965.0,1.0
left cervical lymph node,965.0,1.0
vulvar melanoma,975.0,1.0
